Loading
A phase 2 trial of cisplatin, gemcitabine and nab-paclitaxel in pancreatic cancer, run by Emory University, now recruiting.
Gemcitabine, Cisplatin and Nab-Paclitaxel as Neoadjuvant Treatment for Patients With Resectable or Borderline Resectable Pancreatic Cancer is a phase 2, interventional study registered as NCT06423326 by Emory University, with a registry enrolment figure of 36 participants, started 2024-08-06 and due to reach its primary completion in 2026-12-31. Interventions recorded: Biopsy; Biospecimen Collection; Cisplatin; Computed Tomography; Gemcitabine; Magnetic Resonance Imaging; Nab-paclitaxel; Pancreatic Surgical Procedure. Conditions listed: Borderline Resectable Pancreatic Ductal Adenocarcinoma; Resectable Pancreatic Adenocarcinoma; Stage I Pancreatic Cancer AJCC v8; Stage II Pancreatic Cancer AJCC v8; Stage III Pancreatic Cancer AJCC v8. Primary outcome: Clinical Response Rate to Neoadjuvant Chemotherapy. Pancreatic eligibility wording from the registry: "* Histologically or cytologically confirmed - resectable and borderline resectable pancreatic ductal adenocarcinoma". Sites: United States. No results are recorded here; the registry entry is the source.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Borderline resectable pancreatic ductal adenocarcinoma, Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites) and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Cisplatin and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Resectable pancreatic ductal adenocarcinoma, Pancreatic cancer trials open today (registry snapshot and UK sites), Gemcitabine and the tag pancreatic-deep-dive.
Shares Nab-paclitaxel, Platinum agents, Pancreatic cancer trials open today (registry snapshot and UK sites), Cisplatin and the tag pancreatic-deep-dive.